-
1
-
-
0026344803
-
Dose intensity as a therapeutic strategy in breast cancer
-
Osborne CK. Dose intensity as a therapeutic strategy in breast cancer. Breast Cancer Res Treat 1991;20:S11-S14.
-
(1991)
Breast Cancer Res Treat
, vol.20
-
-
Osborne, C.K.1
-
2
-
-
0029187792
-
High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer : Yes
-
Philadelphia : Lippincott Company.
-
Peters WP. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer : Yes. In : Important advances in oncology 1995. Philadelphia : Lippincott Company. 1995: 215-230.
-
(1995)
Important Advances in Oncology 1995
, pp. 215-230
-
-
Peters, W.P.1
-
3
-
-
13044254000
-
L'évaluation des facteurs de croissance hématopoïétiques (FCH) : De la minimisation des coûts à une véritable analyse économique
-
Le Corroller AG, Moatti JP, Detournay B, Fagnani F, Biaise D, Maraninchi D. L'évaluation des facteurs de croissance hématopoïétiques (FCH) : de la minimisation des coûts à une véritable analyse économique. Cah Oncol 1993;2:267-273.
-
(1993)
Cah Oncol
, vol.2
, pp. 267-273
-
-
Le Corroller, A.G.1
Moatti, J.P.2
Detournay, B.3
Fagnani, F.4
Biaise, D.5
Maraninchi, D.6
-
4
-
-
0344834092
-
Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation
-
Sheridan WP, Morstyn G, Wolf M et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989;2:891-5.
-
(1989)
Lancet
, vol.2
, pp. 891-895
-
-
Sheridan, W.P.1
Morstyn, G.2
Wolf, M.3
-
5
-
-
0027019408
-
Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor
-
Schwartzberg LS, Birch R, Hazelton B, Tauer KW, Lee P, Altemose R et al. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J Hematotherapy 1992;1:317-327.
-
(1992)
J Hematotherapy
, vol.1
, pp. 317-327
-
-
Schwartzberg, L.S.1
Birch, R.2
Hazelton, B.3
Tauer, K.W.4
Lee, P.5
Altemose, R.6
-
6
-
-
0028255992
-
Randomized study of growth factors post-peripheral-blood stem-cell transplant : Neutrophil recovery is improved with modest clinical benefit
-
Spitzer G, Adkins DR, Spencer V, et al. Randomized study of growth factors post-peripheral-blood stem-cell transplant : neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 1994; 12:661-670.
-
(1994)
J Clin Oncol
, vol.12
, pp. 661-670
-
-
Spitzer, G.1
Adkins, D.R.2
Spencer, V.3
-
8
-
-
0026504705
-
Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy
-
Sheridan WP, Begley CG, Juttner CA, Szer J, Bik To L, Maher D et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. The Lancet 1992;339:640-644.
-
(1992)
The Lancet
, vol.339
, pp. 640-644
-
-
Sheridan, W.P.1
Begley, C.G.2
Juttner, C.A.3
Szer, J.4
Bik To, L.5
Maher, D.6
-
9
-
-
0027413697
-
Comparative effects of granulocytemacrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating Factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy
-
Peters WP, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C et al. Comparative effects of granulocytemacrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating Factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993;817:1709-1719.
-
(1993)
Blood
, vol.817
, pp. 1709-1719
-
-
Peters, W.P.1
Rosner, G.2
Ross, M.3
Vredenburgh, J.4
Meisenberg, B.5
Gilbert, C.6
-
10
-
-
0029875452
-
The clinical effectiveness and financial impact of utilizing peripheral blood progenitor cell as rescue therapy following autologous bone marrow transplant
-
Kucharski AJ, Ghalie R, Greenstein S, Matuszewki K. The clinical effectiveness and financial impact of utilizing peripheral blood progenitor cell as rescue therapy following autologous bone marrow transplant. International Journal of Technology Assessment in Health Care 1996;72;1: 172-179.
-
(1996)
International Journal of Technology Assessment in Health Care
, vol.72
, Issue.1
, pp. 172-179
-
-
Kucharski, A.J.1
Ghalie, R.2
Greenstein, S.3
Matuszewki, K.4
-
11
-
-
0027953956
-
L'évaluation économique du G-CSF en thérapeutique cancérologique : Deux études françaises
-
Le Corroller AG, Moatti JP, Detournay B, Fagnani F, Biaise D et al. L'évaluation économique du G-CSF en thérapeutique cancérologique : deux études françaises. La Presse Médicale 1994;23;24:1105-1109.
-
(1994)
La Presse Médicale
, vol.23
, Issue.24
, pp. 1105-1109
-
-
Le Corroller, A.G.1
Moatti, J.P.2
Detournay, B.3
Fagnani, F.4
Biaise, D.5
-
12
-
-
0027538580
-
Pharmacoeconomic issues in the use of granulocyte-macrophage colony-stimulating factor for bone marrow transplantation or chemotherapy-induced neutropenia
-
Weber RJ. Pharmacoeconomic issues in the use of granulocyte-macrophage colony-stimulating factor for bone marrow transplantation or chemotherapy-induced neutropenia. Clinical Therapeutics 1993;75; 1:180-191.
-
(1993)
Clinical Therapeutics
, vol.75
, Issue.1
, pp. 180-191
-
-
Weber, R.J.1
-
13
-
-
13044262294
-
Analyse médico-économique de l'activité hospitalière
-
Ministère du Travail et des Affaires Sociales Numéro spécial - mai
-
Le PMSI. Analyse médico-économique de l'activité hospitalière. Ministère du Travail et des Affaires Sociales. La lettre d'Informations hospitalières - Numéro spécial - mai 1996.
-
(1996)
La Lettre d'Informations Hospitalières
-
-
Le, P.M.S.I.1
-
14
-
-
84876138133
-
-
Fascicule spécial no 95-5 bis
-
Echelle Nationale de Coûts Relatifs par Groupe Homogène de Malade 1995. Bulletin Officiel. Fascicule spécial no 95-5 bis.
-
Bulletin Officiel
-
-
|